Froedtert Hospital
Milwaukee, Wisconsin, 53226, United States
NCT Number: NCT02348684
The association between radiation exposure and cardiac disease is well recognized, it is not fully understood if there exists an optimal or "safe" radiation dose-volume relationship.
Looking for future studies?
Notify Me18 year–95 year
Female
Observational
Milwaukee, Wisconsin, 53226, United States
Identification of "safe" dose volume constraints (DVC) for the heart from breast cancer radiotherapy would permit maximal oncologic benefit from radiation, identifying which patients require more complicated and resource consumptive radiation methods such as respiratory-gating or intensity modulated radiotherapy (IMRT) and establish patients who need targeted follow-up for their long term cardiac risk. Two recent technical developments now make it conceivable to identify the dose-volume relationship between heart dose and subsequent cardiac event risk: 1. CT based three dimensional conformal radiation delivery methods (3DCRT) where the precise radiation dose to any given heart volume is known, and 2. Cardiac MRI (CMR) that is more sensitive to prior methods of cardiac evaluation (e.g. SPECT) for detecting and measuring cardiac injury.
An MRI, subject health questionnaire, clinical and dosimetric data will be included in the analysis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Radiation Therapy treatment between 2000 and 2007.
Other names: Regional nodal irradiation following lumpectomy/mastectomy.
Time frame: day of MRI scan
Cardiac MRI parameters include Left Ventricular (LV) ejection fraction, LV mass (indexed), LV dimensions, extracellular volume (ECV), and late gadolinium enhancement (LGE).
Time frame: the day of MRI
LVEF
Medical College of Wisconsin
Other
Pilot Study to Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation in Women Treated for Node Positive Breast Cancer With Three- Dimensional Conformal Radiation Therapy (3DCRT)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07085442
Axilla; Breast, Axillary Lymph Nodes Dissection
Burnley, United Kingdom
View Trial DetailsNCT03413761
Node Negative Breast Cancer, Node Positive Breast Cancer
View Trial DetailsNCT00189670
Node Positive Breast Cancer
View Trial DetailsNCT06790264
Breast Cancer Invasive, Node Positive Breast Cancer
Milan, Italy
View Trial Details